Kepler Capital Markets Reiterates €63.00 Price Target for Brenntag (BNR)

Share on StockTwits

Brenntag (FRA:BNR) has been given a €63.00 ($73.26) price target by investment analysts at Kepler Capital Markets in a report released on Wednesday. The firm currently has a “buy” rating on the stock. Kepler Capital Markets’ price objective would suggest a potential upside of 41.00% from the company’s previous close.

Several other research analysts also recently weighed in on BNR. Berenberg Bank set a €60.00 ($69.77) target price on shares of Brenntag and gave the company a “neutral” rating in a research note on Wednesday, August 8th. Warburg Research set a €60.00 ($69.77) target price on shares of Brenntag and gave the company a “buy” rating in a research note on Wednesday, August 8th. UBS Group set a €50.00 ($58.14) target price on shares of Brenntag and gave the company a “neutral” rating in a research note on Monday, August 20th. equinet set a €59.80 ($69.53) target price on shares of Brenntag and gave the company a “buy” rating in a research note on Wednesday, August 8th. Finally, Deutsche Bank set a €55.00 ($63.95) target price on shares of Brenntag and gave the company a “buy” rating in a research note on Wednesday, August 8th. One research analyst has rated the stock with a sell rating, four have given a hold rating and twelve have issued a buy rating to the company’s stock. Brenntag presently has a consensus rating of “Buy” and a consensus target price of €58.49 ($68.01).

FRA:BNR opened at €44.68 ($51.95) on Wednesday. Brenntag has a 52-week low of €43.06 ($50.07) and a 52-week high of €56.25 ($65.41).

About Brenntag

Brenntag AG, a chemical distribution company, purchases and supplies industrial and specialty chemicals in Europe, the Middle East, Africa, North America, Latin America, the Asia Pacific, and internationally. The company also provides value added services. It serves customers in various end-market industries, such as adhesives, paints, oil and gas, food, water treatment, personal care, and pharmaceuticals.

See Also: Market Capitalization in the Stock Market

Analyst Recommendations for Brenntag (FRA:BNR)

Receive News & Ratings for Brenntag Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Brenntag and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply